Firdapse: “Now Approved” Page

Dec 5, 2018Dec 5, 2018

Brand: Firdapse (amifampridine), Tablets
Parent Company: Catalyst Pharmaceuticals
Drug Type: Prescription
Drug Category: Immunology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.firdapse.com/
HCP Website:

: Desktop

: Mobile

The gallery of digital pharma marketing screenshots.

Firdapse: “Now Approved” Page

Your Email

Name
This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.